Research Article
Serum Parathyroid Hormone Is a New Potential Risk Factor in Multiple Myeloma
Table 2
Time-dependent Cox regression analysis for the overall survival in MM patients.
| Factors | Hazard ratio | 95% CI | |
| PTH | | | | ≥68.3 | 1.710 | 0.050~58.212 | 0.766* | <68.3 | 1.0 (reference) | | | Age | 1.004 | 0.952~1.058 | 0.894 | Sex | | | | Male versus Female | 1.294 | 0.422~3.968 | 0.652 | ISS stage | | | | I versus II | 0.138 | 0.015~1.250 | 0.078 | I versus III | 0.171 | 0.017~1.683 | 0.130 | Albumin | 0.136 | 0.038~0.491 | 0.002† | 2-MG | 1.0 | 1.000~1.000 | 0.963 | Calcium | 1.271 | 0.965~1.675 | 0.088 | Creatinine | 1.126 | 0.735~1.725 | 0.586 | Hemoglobin | 1.097 | 0.824~1.462 | 0.526 | FLC ratio | 1.0 | 1.000~1.000 | 0.030† |
|
|
All parameters considered; the overall value of PTH was 0.557. Statistical significance. PTH: parathyroid hormone; FLC: serum free light chain.
|